SJ
Therapeutic Areas
Trio Medicines Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Netazepide | Gastric Neuroendocrine Tumors (g-NETs) | Phase 3 (Partner sought) |
| Ceclazepide | Acid-related conditions | Preclinical/Phase 1 |
| TR4 | Not specified (Selective β2-adrenoceptor antagonist) | Preclinical |
| TR8 | Not specified (Formyl peptide receptor 2 agonist) | Preclinical |